| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 703P9YDP7F |
| InChI Key | NGWSFRIPKNWYAO-SHTIJGAHSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H20ClNO4 |
| Molecular Weight | 313.78 |
| AlogP | 1.13 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 75.63 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 21.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | 20S proteosome inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Threonine protease
Threonine protease PBT clan
Threonine protease T1A subfamily
|
- | 4-22 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glioblastoma | 3 | D005909 | ClinicalTrials |
| Ependymoma | 2 | D004806 | ClinicalTrials |
| Ependymoma | 2 | D004806 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 437742-34-2 |
| ChEBI | 48045 |
| ChEMBL | CHEMBL371405 |
| DrugBank | DB11762 |
| FDA SRS | 703P9YDP7F |
| PubChem | 11347535 |
| SureChEMBL | SCHEMBL151667 |
| ZINC | ZINC000003990364 |